TESK1
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O95394 | S64 | Sugiyama | PGM3 AGM1 | LLAVLRSKQTKSTIGVMVtAsHNPEEDNGVKLVDPLGEMLA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00505 | Y179 | Sugiyama | GOT2 KYAT4 | KPTWGNHtPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDIS |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y359 | Sugiyama | ASS1 ASS | AKSQERVEGKVQVSVLKGQVyILGRESPLSLYNEELVSMNV |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | S344 | Sugiyama | HNRNPA2B1 HNRPA2B1 | sRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___________ |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | S3 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CFL1 CFL | __________________MAsGVAVsDGVIKVFNDMKVRKs |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28074 | Y171 | Sugiyama | PSMB5 LMPX MB1 X | GMGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGS |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30101 | S155 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ASVPLRTEEEFKKFISDKDAsIVGFFDDsFsEAHsEFLKAA |
| P30101 | S163 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | EEFKKFISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYR |
| P30101 | S165 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FKKFISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYRFA |
| P30101 | S169 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYRFAHTNV |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40227 | S246 | Sugiyama | CCT6A CCT6 CCTZ | EDAyILTCNVSLEYEKTEVNsGFFyKSAEEREKLVKAERKF |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46940 | Y43 | Sugiyama | IQGAP1 KIAA0051 | NERLTAEEMDERRRQNVAyEyLCHLEEAKRWMEACLGEDLP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P52209 | S126 | Sugiyama | PGD PGDH | YRDTTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGN |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q15181 | Y90 | Sugiyama | PPA1 IOPPP PP | KQDVKKGKLRyVANLFPyKGyIWNyGAIPQtWEDPGHNDKH |
| Q15569 | S220 | SIGNOR|iPTMNet|EPSD | TESK1 | AEKIPVYREGARKEPLAVVGsPYWMAPEVLRGELYDEKADV |
| Q15569 | S353 | Sugiyama | TESK1 | QGSVARGGPSATLPRPDPRLsRsRSDLFLPPsPEsPPNWGD |
| Q15569 | S355 | Sugiyama | TESK1 | SVARGGPSATLPRPDPRLsRsRSDLFLPPsPEsPPNWGDNL |
| Q15569 | S364 | Sugiyama | TESK1 | TLPRPDPRLsRsRSDLFLPPsPEsPPNWGDNLTRVNPFSLR |
| Q15569 | S367 | Sugiyama | TESK1 | RPDPRLsRsRSDLFLPPsPEsPPNWGDNLTRVNPFSLREDL |
| Q15569 | S437 | Sugiyama | TESK1 | PLVTTPETLVQPGTPARRCRsLPssPELPRRMEtALPGPGP |
| Q15569 | S440 | Sugiyama | TESK1 | TTPETLVQPGTPARRCRsLPssPELPRRMEtALPGPGPPAV |
| Q15569 | S441 | Sugiyama | TESK1 | TPETLVQPGTPARRCRsLPssPELPRRMEtALPGPGPPAVG |
| Q15569 | S46 | Sugiyama | TESK1 | PGGTGGGPGRGRPSSYRALRsAVssLARVDDFHCAEKIGAG |
| Q15569 | S49 | Sugiyama | TESK1 | TGGGPGRGRPSSYRALRsAVssLARVDDFHCAEKIGAGFFS |
| Q15569 | S50 | Sugiyama | TESK1 | GGGPGRGRPSSYRALRsAVssLARVDDFHCAEKIGAGFFSE |
| Q15569 | S603 | Sugiyama | TESK1 | MCPRPTPAVARyRNLNCEAGsLLCHRGHHAKPPtPSLQLPG |
| Q15569 | S626 | Sugiyama | TESK1 | CHRGHHAKPPtPSLQLPGARs____________________ |
| Q15569 | S79 | Sugiyama | TESK1 | CAEKIGAGFFSEVYKVRHRQsGQVMVLKMNKLPSNRGNtLR |
| Q15569 | T450 | Sugiyama | TESK1 | TPARRCRsLPssPELPRRMEtALPGPGPPAVGPSAEEKMEC |
| Q15569 | T616 | Sugiyama | TESK1 | NLNCEAGsLLCHRGHHAKPPtPSLQLPGARs__________ |
| Q15569 | T97 | Sugiyama | TESK1 | RQsGQVMVLKMNKLPSNRGNtLREVQLMNRLRHPNILRFMG |
| Q15569 | Y594 | Sugiyama | TESK1 | GPFSFGFLSMCPRPTPAVARyRNLNCEAGsLLCHRGHHAKP |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q92526 | S246 | Sugiyama | CCT6B | EDAFILICNVSLEYEKTEVNsGFFyKTAEEKEKLVKAERKF |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9Y281 | S3 | SIGNOR | CFL2 | __________________MAsGVtVNDEVIKVFNDMKVRKs |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.039202e-09 | 8.219 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.039202e-09 | 8.219 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.021649e-07 | 6.045 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.394933e-06 | 5.621 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.921328e-05 | 4.407 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.280095e-05 | 4.202 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.074901e-04 | 3.969 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.661782e-05 | 4.015 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.168199e-04 | 3.932 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.937816e-04 | 3.713 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.503290e-04 | 3.346 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.345144e-04 | 3.362 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.261728e-04 | 3.279 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.261728e-04 | 3.279 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.842336e-04 | 3.233 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.842336e-04 | 3.233 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.620909e-04 | 3.179 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.620909e-04 | 3.179 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.766865e-04 | 3.110 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.638715e-04 | 3.117 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.443433e-04 | 3.025 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.443433e-04 | 3.025 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.991541e-04 | 3.000 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.083798e-03 | 2.965 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.085478e-03 | 2.964 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.124406e-03 | 2.949 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.367377e-03 | 2.864 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.367377e-03 | 2.864 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.367377e-03 | 2.864 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.417347e-03 | 2.849 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.554404e-03 | 2.808 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.847254e-03 | 2.733 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 2.000186e-03 | 2.699 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.103306e-03 | 2.677 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.238025e-03 | 2.650 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.431166e-03 | 2.614 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.388321e-03 | 2.622 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.497291e-03 | 2.603 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.561570e-03 | 2.591 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.561570e-03 | 2.591 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.823492e-03 | 2.549 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.886611e-03 | 2.540 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.927709e-03 | 2.533 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.239698e-03 | 2.489 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.621767e-03 | 2.441 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.176974e-03 | 2.379 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.667855e-03 | 2.331 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.667855e-03 | 2.331 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.196134e-03 | 2.284 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.546112e-03 | 2.256 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.001761e-03 | 2.222 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.061364e-03 | 2.217 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.178429e-03 | 2.144 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.513833e-03 | 2.124 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.017526e-03 | 2.154 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.357120e-03 | 2.133 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.513833e-03 | 2.124 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.269985e-03 | 2.082 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.269985e-03 | 2.082 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.010463e-03 | 2.096 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.102385e-03 | 2.091 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.031747e-02 | 1.986 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.031747e-02 | 1.986 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 9.526648e-03 | 2.021 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 9.526648e-03 | 2.021 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.302496e-03 | 2.031 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.885757e-03 | 2.051 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.032883e-03 | 2.044 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 9.526648e-03 | 2.021 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 9.526648e-03 | 2.021 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.982187e-03 | 2.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.005346e-02 | 1.998 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.086263e-02 | 1.964 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.156575e-02 | 1.937 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.113490e-02 | 1.953 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.227618e-02 | 1.911 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 1.230081e-02 | 1.910 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.255398e-02 | 1.901 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.456073e-02 | 1.837 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.532914e-02 | 1.814 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.383956e-02 | 1.859 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.383956e-02 | 1.859 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.380149e-02 | 1.860 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.532914e-02 | 1.814 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.487981e-02 | 1.827 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 1.278880e-02 | 1.893 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.532914e-02 | 1.814 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.633736e-02 | 1.787 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.545903e-02 | 1.811 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.648243e-02 | 1.783 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.648243e-02 | 1.783 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.696517e-02 | 1.770 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.696517e-02 | 1.770 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.822515e-02 | 1.739 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.822515e-02 | 1.739 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.854347e-02 | 1.732 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.102421e-02 | 1.677 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.302494e-02 | 1.638 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.229185e-02 | 1.652 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.164588e-02 | 1.665 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.229185e-02 | 1.652 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.420163e-02 | 1.616 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.420163e-02 | 1.616 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.475557e-02 | 1.606 | 1 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.348919e-02 | 1.629 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 2.231780e-02 | 1.651 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.522771e-02 | 1.598 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.031204e-02 | 1.518 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.031204e-02 | 1.518 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.821323e-02 | 1.550 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.617593e-02 | 1.582 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.598924e-02 | 1.585 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.031204e-02 | 1.518 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.821323e-02 | 1.550 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.031204e-02 | 1.518 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.031204e-02 | 1.518 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.755348e-02 | 1.560 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.821323e-02 | 1.550 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.728984e-02 | 1.564 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.957580e-02 | 1.529 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.835627e-02 | 1.547 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.023375e-02 | 1.520 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.000338e-02 | 1.523 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.031204e-02 | 1.518 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.063602e-02 | 1.514 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.063602e-02 | 1.514 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.063602e-02 | 1.514 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.063602e-02 | 1.514 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.063602e-02 | 1.514 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.247089e-02 | 1.489 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.247089e-02 | 1.489 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.247089e-02 | 1.489 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.247089e-02 | 1.489 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.063925e-02 | 1.391 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.063925e-02 | 1.391 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.063925e-02 | 1.391 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.696294e-02 | 1.432 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.929332e-02 | 1.406 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.714954e-02 | 1.430 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.105931e-02 | 1.387 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.105931e-02 | 1.387 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.734851e-02 | 1.428 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.063925e-02 | 1.391 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.468833e-02 | 1.460 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.737107e-02 | 1.427 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.714954e-02 | 1.430 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.813696e-02 | 1.419 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.468833e-02 | 1.460 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.440282e-02 | 1.463 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.696294e-02 | 1.432 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.471966e-02 | 1.459 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.049219e-02 | 1.393 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.167809e-02 | 1.380 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.324970e-02 | 1.364 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.411589e-02 | 1.355 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.411589e-02 | 1.355 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.626303e-02 | 1.335 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.660540e-02 | 1.332 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.660540e-02 | 1.332 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.660540e-02 | 1.332 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.660540e-02 | 1.332 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.734594e-02 | 1.325 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.734594e-02 | 1.325 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.772138e-02 | 1.321 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.829147e-02 | 1.316 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.863129e-02 | 1.313 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.914529e-02 | 1.309 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.055601e-02 | 1.296 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.078362e-02 | 1.294 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.134327e-02 | 1.290 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.173429e-02 | 1.286 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.173429e-02 | 1.286 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.290354e-02 | 1.277 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.437111e-02 | 1.265 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.437111e-02 | 1.265 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.033892e-02 | 1.219 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.003744e-02 | 1.155 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.003744e-02 | 1.155 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.003744e-02 | 1.155 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.033892e-02 | 1.219 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.705451e-02 | 1.244 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.805330e-02 | 1.167 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.033892e-02 | 1.219 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 7.003744e-02 | 1.155 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.705451e-02 | 1.244 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.255616e-02 | 1.204 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.609208e-02 | 1.251 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.406567e-02 | 1.130 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.822964e-02 | 1.166 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.033892e-02 | 1.219 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.003744e-02 | 1.155 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.255616e-02 | 1.204 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.768913e-02 | 1.169 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.112790e-02 | 1.148 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.112790e-02 | 1.148 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.445267e-02 | 1.191 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.112790e-02 | 1.148 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.978326e-02 | 1.223 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.704183e-02 | 1.113 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.704183e-02 | 1.113 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.963645e-02 | 1.099 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.963645e-02 | 1.099 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.963645e-02 | 1.099 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.913696e-02 | 1.050 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.853999e-02 | 1.006 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.853999e-02 | 1.006 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 9.853999e-02 | 1.006 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 1.078465e-01 | 0.967 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 1.351970e-01 | 0.869 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.529659e-01 | 0.815 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.789410e-01 | 0.747 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.789410e-01 | 0.747 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.789410e-01 | 0.747 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.874223e-01 | 0.727 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.958164e-01 | 0.708 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.958164e-01 | 0.708 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.204850e-01 | 0.657 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.285396e-01 | 0.641 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.285396e-01 | 0.641 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.285396e-01 | 0.641 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.285396e-01 | 0.641 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.285396e-01 | 0.641 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.667228e-02 | 1.062 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.865371e-02 | 1.052 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.676753e-02 | 1.014 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.756670e-01 | 0.755 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.160650e-01 | 0.935 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.273623e-01 | 0.895 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.123469e-01 | 0.673 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.285396e-01 | 0.641 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.053803e-01 | 0.977 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.053803e-01 | 0.977 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.204850e-01 | 0.657 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.261740e-01 | 0.899 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.789410e-01 | 0.747 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.170575e-01 | 0.932 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.261740e-01 | 0.899 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.703719e-01 | 0.769 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.789410e-01 | 0.747 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.290427e-01 | 0.889 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.084418e-02 | 1.092 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.180771e-01 | 0.661 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.585914e-02 | 1.018 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.617138e-01 | 0.791 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.255893e-01 | 0.901 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.719858e-01 | 0.765 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.257642e-01 | 0.900 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.078465e-01 | 0.967 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.441273e-01 | 0.841 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.617138e-01 | 0.791 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.204850e-01 | 0.657 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.529659e-01 | 0.815 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.703719e-01 | 0.769 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.884194e-02 | 1.005 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.261740e-01 | 0.899 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 1.255893e-01 | 0.901 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.204850e-01 | 0.657 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 7.963645e-02 | 1.099 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.963645e-02 | 1.099 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.853999e-02 | 1.006 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 9.853999e-02 | 1.006 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.078465e-01 | 0.967 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.261740e-01 | 0.899 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.261740e-01 | 0.899 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.041243e-01 | 0.690 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.123469e-01 | 0.673 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.471129e-02 | 1.024 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.123469e-01 | 0.673 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.830665e-01 | 0.737 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.343582e-01 | 0.630 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.756670e-01 | 0.755 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.958164e-01 | 0.708 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.065417e-02 | 1.043 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.703719e-01 | 0.769 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.683178e-01 | 0.774 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.466257e-01 | 0.834 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.084418e-02 | 1.092 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.078465e-01 | 0.967 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.351970e-01 | 0.869 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.086831e-01 | 0.964 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.529659e-01 | 0.815 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.430697e-01 | 0.844 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.963645e-02 | 1.099 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.529659e-01 | 0.815 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.529659e-01 | 0.815 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.789410e-01 | 0.747 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.789410e-01 | 0.747 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.204850e-01 | 0.657 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.285396e-01 | 0.641 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.261887e-01 | 0.646 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.466257e-01 | 0.834 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.789410e-01 | 0.747 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.244421e-01 | 0.649 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 8.913696e-02 | 1.050 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.116577e-01 | 0.952 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.438041e-01 | 0.842 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.441273e-01 | 0.841 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.958164e-01 | 0.708 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.123469e-01 | 0.673 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.364912e-01 | 0.865 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.963645e-02 | 1.099 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.441273e-01 | 0.841 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.529659e-01 | 0.815 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.529659e-01 | 0.815 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.529659e-01 | 0.815 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.529659e-01 | 0.815 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.529659e-01 | 0.815 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.617138e-01 | 0.791 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 2.041243e-01 | 0.690 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.182930e-01 | 0.927 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.584244e-01 | 0.800 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.618980e-02 | 1.065 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.041243e-01 | 0.690 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.041243e-01 | 0.690 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.358625e-01 | 0.627 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.343231e-01 | 0.872 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.198827e-02 | 1.036 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.963645e-02 | 1.099 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.963645e-02 | 1.099 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.170575e-01 | 0.932 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.351970e-01 | 0.869 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.958164e-01 | 0.708 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.958164e-01 | 0.708 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.930876e-02 | 1.049 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.204853e-01 | 0.919 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.610241e-01 | 0.793 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.789410e-01 | 0.747 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.874223e-01 | 0.727 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.958164e-01 | 0.708 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.285396e-01 | 0.641 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.942487e-01 | 0.712 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.078465e-01 | 0.967 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.703719e-01 | 0.769 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.874223e-01 | 0.727 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.285396e-01 | 0.641 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.320515e-01 | 0.634 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.261740e-01 | 0.899 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.930876e-02 | 1.049 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.285396e-01 | 0.641 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.018097e-01 | 0.992 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.170575e-01 | 0.932 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.351970e-01 | 0.869 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.789410e-01 | 0.747 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.204850e-01 | 0.657 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.430697e-01 | 0.844 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.709424e-01 | 0.767 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.182930e-01 | 0.927 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.055161e-01 | 0.687 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.618980e-02 | 1.065 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.078465e-01 | 0.967 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.703719e-01 | 0.769 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.874223e-01 | 0.727 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.021057e-01 | 0.991 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.021057e-01 | 0.991 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.073169e-01 | 0.969 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.017518e-01 | 0.695 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.092880e-01 | 0.679 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.438041e-01 | 0.842 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.908080e-02 | 1.050 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.703719e-01 | 0.769 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.123469e-01 | 0.673 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.395326e-01 | 0.855 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.863231e-01 | 0.730 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.261740e-01 | 0.899 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.537915e-01 | 0.813 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.078465e-01 | 0.967 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.170575e-01 | 0.932 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.886027e-02 | 1.005 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.915293e-01 | 0.718 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.785864e-01 | 0.748 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.629723e-02 | 1.064 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.170887e-01 | 0.931 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.231102e-02 | 1.035 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.486262e-01 | 0.828 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.155232e-01 | 0.667 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.874223e-01 | 0.727 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.123469e-01 | 0.673 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.930876e-02 | 1.049 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.830665e-01 | 0.737 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.559562e-01 | 0.807 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.809782e-01 | 0.742 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.886027e-02 | 1.005 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.646637e-01 | 0.783 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.123469e-01 | 0.673 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.244421e-01 | 0.649 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.523694e-01 | 0.817 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.722624e-01 | 0.764 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.348074e-01 | 0.629 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.221587e-01 | 0.913 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.986819e-01 | 0.702 | 1 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.041243e-01 | 0.690 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.124708e-01 | 0.673 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.617138e-01 | 0.791 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.584244e-01 | 0.800 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.930876e-02 | 1.049 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.041243e-01 | 0.690 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 2.055161e-01 | 0.687 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.703719e-01 | 0.769 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.244421e-01 | 0.649 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.204850e-01 | 0.657 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 2.365114e-01 | 0.626 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.365114e-01 | 0.626 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.365114e-01 | 0.626 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.365114e-01 | 0.626 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.365114e-01 | 0.626 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.365114e-01 | 0.626 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.415190e-01 | 0.617 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.434914e-01 | 0.614 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.434914e-01 | 0.614 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 2.434947e-01 | 0.614 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.444014e-01 | 0.612 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.444014e-01 | 0.612 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.444014e-01 | 0.612 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.444014e-01 | 0.612 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.473150e-01 | 0.607 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.480881e-01 | 0.605 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.480881e-01 | 0.605 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.511374e-01 | 0.600 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.522103e-01 | 0.598 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 2.522103e-01 | 0.598 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.522103e-01 | 0.598 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.536154e-01 | 0.596 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.549615e-01 | 0.594 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.549615e-01 | 0.594 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.549615e-01 | 0.594 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.563858e-01 | 0.591 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.587869e-01 | 0.587 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.587869e-01 | 0.587 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 2.599389e-01 | 0.585 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.619393e-01 | 0.582 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.675084e-01 | 0.573 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.675882e-01 | 0.573 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.675882e-01 | 0.573 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.675882e-01 | 0.573 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.675882e-01 | 0.573 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.675882e-01 | 0.573 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.675882e-01 | 0.573 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.675882e-01 | 0.573 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.675882e-01 | 0.573 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.702983e-01 | 0.568 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.751588e-01 | 0.560 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.751588e-01 | 0.560 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.751588e-01 | 0.560 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.751588e-01 | 0.560 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.751588e-01 | 0.560 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.758880e-01 | 0.559 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.776696e-01 | 0.556 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.817424e-01 | 0.550 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.826517e-01 | 0.549 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.826517e-01 | 0.549 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.826517e-01 | 0.549 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.855651e-01 | 0.544 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.855651e-01 | 0.544 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.900676e-01 | 0.538 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.900676e-01 | 0.538 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.900676e-01 | 0.538 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 2.900676e-01 | 0.538 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 2.900676e-01 | 0.538 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 2.900676e-01 | 0.538 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.900676e-01 | 0.538 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.927231e-01 | 0.534 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.927231e-01 | 0.534 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.974073e-01 | 0.527 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.974073e-01 | 0.527 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.004774e-01 | 0.522 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.046422e-01 | 0.516 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.046422e-01 | 0.516 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.046715e-01 | 0.516 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.046715e-01 | 0.516 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.046715e-01 | 0.516 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.046715e-01 | 0.516 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.046715e-01 | 0.516 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.084480e-01 | 0.511 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.118611e-01 | 0.506 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.118611e-01 | 0.506 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.118611e-01 | 0.506 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.122497e-01 | 0.505 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.122497e-01 | 0.505 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.122497e-01 | 0.505 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.148704e-01 | 0.502 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.152724e-01 | 0.501 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.189767e-01 | 0.496 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.189767e-01 | 0.496 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.189767e-01 | 0.496 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.189767e-01 | 0.496 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.189767e-01 | 0.496 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.189767e-01 | 0.496 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.198398e-01 | 0.495 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 3.206837e-01 | 0.494 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.209191e-01 | 0.494 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.209191e-01 | 0.494 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.216833e-01 | 0.493 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.222133e-01 | 0.492 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.227141e-01 | 0.491 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.236275e-01 | 0.490 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.244951e-01 | 0.489 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 3.260193e-01 | 0.487 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.263557e-01 | 0.486 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.274100e-01 | 0.485 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.329894e-01 | 0.478 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.329894e-01 | 0.478 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.329894e-01 | 0.478 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.329894e-01 | 0.478 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.329894e-01 | 0.478 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.329894e-01 | 0.478 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.329894e-01 | 0.478 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.329894e-01 | 0.478 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.329894e-01 | 0.478 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.349580e-01 | 0.475 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 3.350388e-01 | 0.475 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.378620e-01 | 0.471 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.398879e-01 | 0.469 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.398879e-01 | 0.469 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.398879e-01 | 0.469 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.398879e-01 | 0.469 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.398879e-01 | 0.469 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.398879e-01 | 0.469 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.398879e-01 | 0.469 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.424816e-01 | 0.465 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.467155e-01 | 0.460 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.467155e-01 | 0.460 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.467155e-01 | 0.460 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.467155e-01 | 0.460 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.467155e-01 | 0.460 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.467155e-01 | 0.460 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.467155e-01 | 0.460 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.467155e-01 | 0.460 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.467155e-01 | 0.460 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.534728e-01 | 0.452 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.534728e-01 | 0.452 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.534728e-01 | 0.452 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.534728e-01 | 0.452 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.534728e-01 | 0.452 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.537164e-01 | 0.451 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.537164e-01 | 0.451 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.574467e-01 | 0.447 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.574467e-01 | 0.447 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.575996e-01 | 0.447 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.601607e-01 | 0.444 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.601607e-01 | 0.444 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.601607e-01 | 0.444 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.601607e-01 | 0.444 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.601607e-01 | 0.444 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.601607e-01 | 0.444 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.601607e-01 | 0.444 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.601607e-01 | 0.444 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.611694e-01 | 0.442 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.611694e-01 | 0.442 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.632268e-01 | 0.440 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.667798e-01 | 0.436 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.667798e-01 | 0.436 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.667798e-01 | 0.436 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.667798e-01 | 0.436 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.667798e-01 | 0.436 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.716535e-01 | 0.430 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.722892e-01 | 0.429 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.733308e-01 | 0.428 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.733308e-01 | 0.428 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.733308e-01 | 0.428 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.798145e-01 | 0.420 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.798145e-01 | 0.420 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.798145e-01 | 0.420 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.798145e-01 | 0.420 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.798145e-01 | 0.420 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.833316e-01 | 0.416 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.856517e-01 | 0.414 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.862315e-01 | 0.413 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.862315e-01 | 0.413 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.862315e-01 | 0.413 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.862315e-01 | 0.413 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.862315e-01 | 0.413 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.862315e-01 | 0.413 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.869942e-01 | 0.412 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.918319e-01 | 0.407 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.925825e-01 | 0.406 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.925825e-01 | 0.406 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.925825e-01 | 0.406 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.925825e-01 | 0.406 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.967998e-01 | 0.401 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.988681e-01 | 0.399 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.988681e-01 | 0.399 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.988681e-01 | 0.399 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.988681e-01 | 0.399 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.988681e-01 | 0.399 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.988681e-01 | 0.399 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.988681e-01 | 0.399 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.988681e-01 | 0.399 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.988681e-01 | 0.399 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.988681e-01 | 0.399 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.015485e-01 | 0.396 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.015485e-01 | 0.396 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.050891e-01 | 0.392 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.050891e-01 | 0.392 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.080140e-01 | 0.389 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.087653e-01 | 0.389 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.087653e-01 | 0.389 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.112461e-01 | 0.386 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.123580e-01 | 0.385 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.123580e-01 | 0.385 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.128929e-01 | 0.384 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.159400e-01 | 0.381 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.173397e-01 | 0.380 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.173397e-01 | 0.380 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.195112e-01 | 0.377 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.233707e-01 | 0.373 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.233707e-01 | 0.373 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.233707e-01 | 0.373 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.233707e-01 | 0.373 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.233707e-01 | 0.373 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.293396e-01 | 0.367 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.293396e-01 | 0.367 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.293396e-01 | 0.367 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.293396e-01 | 0.367 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.293396e-01 | 0.367 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.293396e-01 | 0.367 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.293396e-01 | 0.367 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.293396e-01 | 0.367 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.293396e-01 | 0.367 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.293396e-01 | 0.367 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.301580e-01 | 0.366 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.326286e-01 | 0.364 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.336841e-01 | 0.363 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.352471e-01 | 0.361 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.352471e-01 | 0.361 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.352471e-01 | 0.361 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.352471e-01 | 0.361 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.352471e-01 | 0.361 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.410937e-01 | 0.355 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.410937e-01 | 0.355 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.410937e-01 | 0.355 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.435042e-01 | 0.353 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.462107e-01 | 0.350 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.468803e-01 | 0.350 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.468803e-01 | 0.350 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.468803e-01 | 0.350 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.468803e-01 | 0.350 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.468803e-01 | 0.350 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.468803e-01 | 0.350 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.468803e-01 | 0.350 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.511385e-01 | 0.346 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.526072e-01 | 0.344 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.526072e-01 | 0.344 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.526072e-01 | 0.344 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.580353e-01 | 0.339 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.582752e-01 | 0.339 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.582752e-01 | 0.339 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.638849e-01 | 0.334 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.638849e-01 | 0.334 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.638849e-01 | 0.334 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.638849e-01 | 0.334 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.638849e-01 | 0.334 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.638849e-01 | 0.334 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.694368e-01 | 0.328 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.694368e-01 | 0.328 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.694368e-01 | 0.328 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.694368e-01 | 0.328 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.701835e-01 | 0.328 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.716785e-01 | 0.326 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.749316e-01 | 0.323 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.803698e-01 | 0.318 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.803698e-01 | 0.318 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.817759e-01 | 0.317 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.857520e-01 | 0.314 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.857520e-01 | 0.314 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.857520e-01 | 0.314 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.910788e-01 | 0.309 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.910788e-01 | 0.309 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.910788e-01 | 0.309 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.910788e-01 | 0.309 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.950544e-01 | 0.305 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.950544e-01 | 0.305 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.963508e-01 | 0.304 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.963508e-01 | 0.304 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.015684e-01 | 0.300 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.015684e-01 | 0.300 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.015684e-01 | 0.300 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.067324e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.067324e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.068811e-01 | 0.295 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.118431e-01 | 0.291 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.118431e-01 | 0.291 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.118431e-01 | 0.291 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.161680e-01 | 0.287 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.169012e-01 | 0.287 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.169012e-01 | 0.287 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.169012e-01 | 0.287 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.169012e-01 | 0.287 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.169012e-01 | 0.287 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.169012e-01 | 0.287 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.219072e-01 | 0.282 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.219072e-01 | 0.282 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.219072e-01 | 0.282 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.268617e-01 | 0.278 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.268617e-01 | 0.278 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.304437e-01 | 0.275 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.366962e-01 | 0.270 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.414208e-01 | 0.266 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.428916e-01 | 0.265 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.428916e-01 | 0.265 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.461742e-01 | 0.263 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.461742e-01 | 0.263 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.520773e-01 | 0.258 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.555346e-01 | 0.255 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.555346e-01 | 0.255 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.555346e-01 | 0.255 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.555346e-01 | 0.255 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.601426e-01 | 0.252 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.601426e-01 | 0.252 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.601426e-01 | 0.252 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.601426e-01 | 0.252 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.601426e-01 | 0.252 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.601426e-01 | 0.252 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.633429e-01 | 0.249 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.647030e-01 | 0.248 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.647030e-01 | 0.248 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.692165e-01 | 0.245 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.692165e-01 | 0.245 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.736835e-01 | 0.241 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.736835e-01 | 0.241 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.781044e-01 | 0.238 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.781044e-01 | 0.238 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.781044e-01 | 0.238 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.781044e-01 | 0.238 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.824797e-01 | 0.235 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.824797e-01 | 0.235 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.903744e-01 | 0.229 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.910955e-01 | 0.228 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.910955e-01 | 0.228 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 5.932182e-01 | 0.227 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 5.932182e-01 | 0.227 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.953369e-01 | 0.225 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.035591e-01 | 0.219 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.036889e-01 | 0.219 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.036889e-01 | 0.219 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.078005e-01 | 0.216 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.078005e-01 | 0.216 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.118696e-01 | 0.213 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.127146e-01 | 0.213 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.158967e-01 | 0.210 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.158967e-01 | 0.210 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.198824e-01 | 0.208 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.198824e-01 | 0.208 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.315943e-01 | 0.200 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.315943e-01 | 0.200 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.322805e-01 | 0.199 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.349315e-01 | 0.197 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.354180e-01 | 0.197 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.364054e-01 | 0.196 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.367292e-01 | 0.196 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.392022e-01 | 0.194 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.429474e-01 | 0.192 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.466539e-01 | 0.189 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.470246e-01 | 0.189 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.539527e-01 | 0.184 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.575457e-01 | 0.182 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.575457e-01 | 0.182 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.611015e-01 | 0.180 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.644874e-01 | 0.178 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.646207e-01 | 0.177 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.681036e-01 | 0.175 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.715505e-01 | 0.173 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.715505e-01 | 0.173 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 6.717574e-01 | 0.173 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.812530e-01 | 0.167 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.816791e-01 | 0.166 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.849859e-01 | 0.164 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.849859e-01 | 0.164 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.849859e-01 | 0.164 | 0 | 0 |
| Translation | R-HSA-72766 | 6.888280e-01 | 0.162 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.914973e-01 | 0.160 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.914973e-01 | 0.160 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.978748e-01 | 0.156 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.010143e-01 | 0.154 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.041214e-01 | 0.152 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.071963e-01 | 0.150 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.084057e-01 | 0.150 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.102395e-01 | 0.149 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.132512e-01 | 0.147 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.148870e-01 | 0.146 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.162318e-01 | 0.145 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.249902e-01 | 0.140 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.274893e-01 | 0.138 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.278495e-01 | 0.138 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.415968e-01 | 0.130 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.417088e-01 | 0.130 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.443952e-01 | 0.128 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.474505e-01 | 0.126 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.490300e-01 | 0.126 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.491890e-01 | 0.125 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.522892e-01 | 0.124 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.548663e-01 | 0.122 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.565962e-01 | 0.121 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.624387e-01 | 0.118 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.673573e-01 | 0.115 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.673573e-01 | 0.115 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.673573e-01 | 0.115 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.697454e-01 | 0.114 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.721747e-01 | 0.112 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.837888e-01 | 0.106 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.860400e-01 | 0.105 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.860400e-01 | 0.105 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.969512e-01 | 0.099 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.969512e-01 | 0.099 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 7.990662e-01 | 0.097 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.990662e-01 | 0.097 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.011592e-01 | 0.096 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.016081e-01 | 0.096 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.032306e-01 | 0.095 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.132700e-01 | 0.090 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.152160e-01 | 0.089 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.209337e-01 | 0.086 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 8.232110e-01 | 0.084 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.246474e-01 | 0.084 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.300749e-01 | 0.081 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.318467e-01 | 0.080 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.336002e-01 | 0.079 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.336002e-01 | 0.079 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.369702e-01 | 0.077 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.439264e-01 | 0.074 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 8.460449e-01 | 0.073 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.607749e-01 | 0.065 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.678927e-01 | 0.062 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.737183e-01 | 0.059 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.785363e-01 | 0.056 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.798053e-01 | 0.056 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.871474e-01 | 0.052 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.971317e-01 | 0.047 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.005207e-01 | 0.046 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.012462e-01 | 0.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.113901e-01 | 0.040 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.259109e-01 | 0.033 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.387138e-01 | 0.027 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.457370e-01 | 0.024 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.487772e-01 | 0.023 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.725556e-01 | 0.012 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.725556e-01 | 0.012 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.888769e-01 | 0.005 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.904874e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.927469e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.935204e-01 | 0.003 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.966103e-01 | 0.001 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.998513e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999987e-01 | 0.000 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.000000e+00 | 0.000 | 1 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.440892e-16 | 15.353 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.562217e-14 | 13.255 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.670919e-11 | 10.573 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.580924e-11 | 10.446 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.340211e-10 | 9.631 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.512482e-10 | 9.186 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.042104e-09 | 8.982 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.052984e-09 | 8.688 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.027758e-09 | 8.220 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.760434e-09 | 8.057 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.445081e-08 | 7.840 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.445081e-08 | 7.840 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.553659e-08 | 7.809 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.417347e-08 | 7.617 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.491402e-08 | 7.348 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.982202e-08 | 7.303 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.044737e-08 | 7.094 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.647559e-08 | 7.063 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.173947e-07 | 6.930 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.356058e-07 | 6.868 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.557813e-07 | 6.807 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.044598e-07 | 6.689 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.289015e-07 | 6.483 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.439884e-07 | 6.264 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.102185e-07 | 6.215 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.110811e-07 | 6.214 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.507082e-07 | 6.125 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.481760e-07 | 6.126 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.591224e-07 | 6.066 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.368813e-07 | 6.077 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.317855e-07 | 6.031 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.102211e-07 | 6.041 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.897836e-07 | 6.004 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.005748e-06 | 5.998 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.133317e-06 | 5.946 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.143587e-06 | 5.942 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.321897e-06 | 5.879 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.299144e-06 | 5.886 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.418008e-06 | 5.848 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.610912e-06 | 5.793 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.736778e-06 | 5.760 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.739523e-06 | 5.760 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.739523e-06 | 5.760 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.009014e-06 | 5.697 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.031740e-06 | 5.692 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.231318e-06 | 5.651 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.231318e-06 | 5.651 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.490058e-06 | 5.604 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.726260e-06 | 5.564 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.984801e-06 | 5.525 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.701492e-06 | 5.432 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.536184e-06 | 5.451 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.140613e-06 | 5.289 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.140613e-06 | 5.289 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.912530e-06 | 5.160 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.447177e-06 | 5.128 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.788017e-06 | 5.009 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.044556e-05 | 4.981 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.859722e-06 | 5.006 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.160398e-05 | 4.935 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.201313e-05 | 4.920 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.431922e-05 | 4.844 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.426769e-05 | 4.846 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.534489e-05 | 4.814 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.538926e-05 | 4.813 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.603145e-05 | 4.795 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.603145e-05 | 4.795 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.736016e-05 | 4.760 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.801515e-05 | 4.744 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.621256e-05 | 4.581 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.753163e-05 | 4.560 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.174202e-05 | 4.498 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.174202e-05 | 4.498 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.174202e-05 | 4.498 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.174202e-05 | 4.498 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.174202e-05 | 4.498 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.007873e-05 | 4.522 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.158104e-05 | 4.501 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.607512e-05 | 4.443 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.673976e-05 | 4.435 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.953491e-05 | 4.403 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.953491e-05 | 4.403 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.112797e-05 | 4.386 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.238191e-05 | 4.373 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.415736e-05 | 4.355 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.415736e-05 | 4.355 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.833879e-05 | 4.316 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.013743e-05 | 4.300 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.070740e-05 | 4.217 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.113308e-05 | 4.148 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.221652e-05 | 4.141 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.377606e-05 | 4.132 | 0 | 0 |
| Translation | R-HSA-72766 | 7.389910e-05 | 4.131 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.929680e-05 | 4.101 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.208845e-05 | 4.086 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.699108e-05 | 4.114 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.755137e-05 | 4.058 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.044875e-05 | 4.044 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.108331e-05 | 4.041 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.197579e-05 | 4.036 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.294976e-05 | 4.032 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.017194e-04 | 3.993 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.023831e-04 | 3.990 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.145264e-04 | 3.941 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.234498e-04 | 3.909 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.660241e-04 | 3.780 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.714086e-04 | 3.766 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.859909e-04 | 3.731 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.921541e-04 | 3.716 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.941817e-04 | 3.712 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.071485e-04 | 3.684 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.158603e-04 | 3.666 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.479473e-04 | 3.606 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.664811e-04 | 3.574 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.901519e-04 | 3.537 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.069233e-04 | 3.513 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.307547e-04 | 3.480 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.307547e-04 | 3.480 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.830997e-04 | 3.417 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.830997e-04 | 3.417 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.819694e-04 | 3.317 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.966864e-04 | 3.304 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.305781e-04 | 3.275 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.827299e-04 | 3.235 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.064631e-04 | 3.217 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.273059e-04 | 3.203 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.310303e-04 | 3.200 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.281891e-04 | 3.138 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.730235e-04 | 3.172 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.744749e-04 | 3.171 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.945997e-04 | 3.158 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.115861e-04 | 3.148 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.357702e-04 | 3.133 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.332200e-04 | 3.135 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.499088e-04 | 3.125 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.610957e-04 | 3.065 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.886603e-04 | 3.051 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.239037e-04 | 3.034 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.102259e-03 | 2.958 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.102259e-03 | 2.958 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.102259e-03 | 2.958 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.105145e-03 | 2.957 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.152721e-03 | 2.938 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.281591e-03 | 2.892 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.289710e-03 | 2.890 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.289710e-03 | 2.890 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.303807e-03 | 2.885 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.393501e-03 | 2.856 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.635877e-03 | 2.786 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.615201e-03 | 2.792 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.635877e-03 | 2.786 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.635877e-03 | 2.786 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.405511e-03 | 2.852 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.773230e-03 | 2.751 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.782200e-03 | 2.749 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.900821e-03 | 2.721 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.938681e-03 | 2.712 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.949439e-03 | 2.710 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.008843e-03 | 2.697 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.057365e-03 | 2.687 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.153817e-03 | 2.667 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.306744e-03 | 2.637 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.324414e-03 | 2.634 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.404365e-03 | 2.619 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.434380e-03 | 2.614 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.467909e-03 | 2.608 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.478179e-03 | 2.606 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.568355e-03 | 2.590 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.611287e-03 | 2.583 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.637605e-03 | 2.579 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.637605e-03 | 2.579 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.326302e-03 | 2.478 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.098702e-03 | 2.509 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.798481e-03 | 2.553 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.227015e-03 | 2.491 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.326643e-03 | 2.478 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.514481e-03 | 2.454 | 1 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.595070e-03 | 2.444 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.806603e-03 | 2.419 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.579435e-03 | 2.339 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.976600e-03 | 2.303 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.265490e-03 | 2.279 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.505539e-03 | 2.259 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.005519e-03 | 2.221 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.185485e-03 | 2.209 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.327813e-03 | 2.199 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.498787e-03 | 2.187 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.760716e-03 | 2.170 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.851386e-03 | 2.164 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.043703e-03 | 2.152 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.044039e-03 | 2.152 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.212937e-03 | 2.142 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.592006e-03 | 2.120 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.795224e-03 | 2.108 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.935996e-03 | 2.100 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.178798e-03 | 2.087 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.578864e-03 | 2.067 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.727753e-03 | 2.059 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.787416e-03 | 2.056 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.787416e-03 | 2.056 | 1 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.149224e-02 | 1.940 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.412302e-03 | 2.026 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.155943e-02 | 1.937 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.123320e-02 | 1.949 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.123320e-02 | 1.949 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.067440e-02 | 1.972 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.006837e-02 | 1.997 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.029671e-02 | 1.987 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.156387e-02 | 1.937 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.160672e-02 | 1.935 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.222283e-02 | 1.913 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.300469e-02 | 1.886 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.300469e-02 | 1.886 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.300469e-02 | 1.886 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.300469e-02 | 1.886 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.312250e-02 | 1.882 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.366239e-02 | 1.864 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.442386e-02 | 1.841 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.462543e-02 | 1.835 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.510119e-02 | 1.821 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.526269e-02 | 1.816 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.552038e-02 | 1.809 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.577751e-02 | 1.802 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.635536e-02 | 1.786 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.704368e-02 | 1.768 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.704579e-02 | 1.768 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.759095e-02 | 1.755 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.787937e-02 | 1.748 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.932906e-02 | 1.714 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.997962e-02 | 1.699 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.014527e-02 | 1.696 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.014527e-02 | 1.696 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.014527e-02 | 1.696 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.025540e-02 | 1.693 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.027328e-02 | 1.693 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.071571e-02 | 1.684 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.074574e-02 | 1.683 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.080660e-02 | 1.682 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.119438e-02 | 1.674 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.216198e-02 | 1.654 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.220598e-02 | 1.654 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.286414e-02 | 1.641 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.323470e-02 | 1.634 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.336244e-02 | 1.631 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.437734e-02 | 1.613 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.474700e-02 | 1.606 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 2.474700e-02 | 1.606 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.474700e-02 | 1.606 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.474700e-02 | 1.606 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.903484e-02 | 1.537 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.903484e-02 | 1.537 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.665926e-02 | 1.574 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.905145e-02 | 1.537 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.077852e-02 | 1.512 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.785245e-02 | 1.555 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.030512e-02 | 1.518 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.903484e-02 | 1.537 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.302583e-02 | 1.481 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.903484e-02 | 1.537 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.822097e-02 | 1.549 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.077736e-02 | 1.512 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.026143e-02 | 1.519 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.903484e-02 | 1.537 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.903484e-02 | 1.537 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.773800e-02 | 1.557 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.303592e-02 | 1.481 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.359504e-02 | 1.474 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.416479e-02 | 1.466 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.427788e-02 | 1.465 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.567030e-02 | 1.448 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.688463e-02 | 1.433 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.688463e-02 | 1.433 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.801496e-02 | 1.420 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.841382e-02 | 1.416 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.212597e-02 | 1.375 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.244016e-02 | 1.372 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 4.289817e-02 | 1.368 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.289817e-02 | 1.368 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.347791e-02 | 1.362 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.347791e-02 | 1.362 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.522405e-02 | 1.345 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.535511e-02 | 1.343 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.600576e-02 | 1.337 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.706103e-02 | 1.327 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.877447e-02 | 1.312 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.877447e-02 | 1.312 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.877447e-02 | 1.312 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.883056e-02 | 1.311 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.888319e-02 | 1.311 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.974463e-02 | 1.303 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.027342e-02 | 1.299 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.429108e-02 | 1.265 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.429108e-02 | 1.265 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.429108e-02 | 1.265 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.429108e-02 | 1.265 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.429108e-02 | 1.265 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.460387e-02 | 1.263 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.567877e-02 | 1.254 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 6.365405e-02 | 1.196 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 6.365405e-02 | 1.196 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.396107e-02 | 1.076 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 8.396107e-02 | 1.076 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.396107e-02 | 1.076 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.396107e-02 | 1.076 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.396107e-02 | 1.076 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.204363e-02 | 1.142 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.832484e-02 | 1.106 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.104327e-02 | 1.148 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.341049e-02 | 1.134 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.330392e-02 | 1.079 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.749016e-02 | 1.240 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.606984e-02 | 1.180 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.749016e-02 | 1.240 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.242465e-02 | 1.205 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.832484e-02 | 1.106 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.242465e-02 | 1.205 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.593703e-02 | 1.181 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.887653e-02 | 1.230 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.593703e-02 | 1.181 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.157789e-02 | 1.211 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.757059e-02 | 1.110 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.242465e-02 | 1.205 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.115449e-02 | 1.091 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 6.365405e-02 | 1.196 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 6.365405e-02 | 1.196 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.365405e-02 | 1.196 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 8.396107e-02 | 1.076 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 8.396107e-02 | 1.076 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.396107e-02 | 1.076 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.593703e-02 | 1.181 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.832484e-02 | 1.106 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.204363e-02 | 1.142 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.338117e-02 | 1.079 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.593703e-02 | 1.181 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.364459e-02 | 1.133 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 8.396107e-02 | 1.076 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 8.396107e-02 | 1.076 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.620247e-02 | 1.250 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.073851e-02 | 1.150 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.826575e-02 | 1.235 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.832484e-02 | 1.106 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.950059e-02 | 1.100 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.489738e-02 | 1.188 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.981040e-02 | 1.156 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.830674e-02 | 1.166 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.044865e-02 | 1.219 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.832484e-02 | 1.106 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.482131e-02 | 1.126 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.713265e-02 | 1.243 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.477025e-02 | 1.072 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.569048e-02 | 1.067 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.569048e-02 | 1.067 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.569048e-02 | 1.067 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.588234e-02 | 1.066 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.588234e-02 | 1.066 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.988051e-02 | 1.046 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.988051e-02 | 1.046 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.092803e-02 | 1.041 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.136984e-02 | 1.039 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.136984e-02 | 1.039 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.136984e-02 | 1.039 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.136984e-02 | 1.039 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.136984e-02 | 1.039 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.136984e-02 | 1.039 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.386574e-02 | 1.027 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.415463e-02 | 1.026 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.415463e-02 | 1.026 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.415463e-02 | 1.026 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.415463e-02 | 1.026 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.415463e-02 | 1.026 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.415463e-02 | 1.026 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.415463e-02 | 1.026 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.419834e-02 | 1.026 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.481229e-02 | 1.023 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.690331e-02 | 1.014 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.752367e-02 | 1.011 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.811394e-02 | 1.008 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.811394e-02 | 1.008 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.811394e-02 | 1.008 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.851080e-02 | 1.007 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.851080e-02 | 1.007 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.009033e-01 | 0.996 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.009033e-01 | 0.996 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.022151e-01 | 0.990 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.022151e-01 | 0.990 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.029470e-01 | 0.987 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.029470e-01 | 0.987 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.029470e-01 | 0.987 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.029470e-01 | 0.987 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.038289e-01 | 0.984 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.043365e-01 | 0.982 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.049932e-01 | 0.979 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.049932e-01 | 0.979 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.049932e-01 | 0.979 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.049932e-01 | 0.979 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.052485e-01 | 0.978 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.232670e-01 | 0.909 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.232670e-01 | 0.909 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.232670e-01 | 0.909 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.422847e-01 | 0.847 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.422847e-01 | 0.847 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.422847e-01 | 0.847 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.422847e-01 | 0.847 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 1.608910e-01 | 0.793 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.608910e-01 | 0.793 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 1.608910e-01 | 0.793 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 1.608910e-01 | 0.793 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.790947e-01 | 0.747 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 1.790947e-01 | 0.747 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.969047e-01 | 0.706 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.969047e-01 | 0.706 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.120510e-01 | 0.951 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.872354e-01 | 0.728 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.951216e-01 | 0.710 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.951216e-01 | 0.710 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.110114e-01 | 0.676 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.110114e-01 | 0.676 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.461240e-01 | 0.835 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.079802e-01 | 0.967 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.074611e-01 | 0.969 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.969047e-01 | 0.706 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.461240e-01 | 0.835 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.232670e-01 | 0.909 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 1.608910e-01 | 0.793 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.830705e-01 | 0.737 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.119987e-01 | 0.951 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.411138e-01 | 0.850 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.969047e-01 | 0.706 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.074611e-01 | 0.969 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.074611e-01 | 0.969 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.996029e-01 | 0.700 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.423779e-01 | 0.847 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.263538e-01 | 0.898 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.772309e-01 | 0.751 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.608910e-01 | 0.793 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.608910e-01 | 0.793 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.951216e-01 | 0.710 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.248903e-01 | 0.903 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.638806e-01 | 0.785 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.232670e-01 | 0.909 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.232670e-01 | 0.909 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.422847e-01 | 0.847 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 1.422847e-01 | 0.847 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.608910e-01 | 0.793 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.638806e-01 | 0.785 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.120510e-01 | 0.951 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.461240e-01 | 0.835 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.564192e-01 | 0.806 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.940518e-01 | 0.712 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.960907e-01 | 0.708 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.716089e-01 | 0.765 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.793958e-01 | 0.746 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.120510e-01 | 0.951 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.921655e-01 | 0.716 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.888738e-01 | 0.724 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.167146e-01 | 0.933 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.262544e-01 | 0.899 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.110114e-01 | 0.676 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.830705e-01 | 0.737 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.872354e-01 | 0.728 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.109213e-01 | 0.955 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.457222e-01 | 0.836 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.736084e-01 | 0.760 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.542171e-01 | 0.812 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.232670e-01 | 0.909 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.969047e-01 | 0.706 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.969047e-01 | 0.706 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.263538e-01 | 0.898 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.793958e-01 | 0.746 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.872354e-01 | 0.728 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.030487e-01 | 0.692 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.830705e-01 | 0.737 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.830705e-01 | 0.737 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.534637e-01 | 0.814 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.790947e-01 | 0.747 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.263538e-01 | 0.898 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.263538e-01 | 0.898 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.120510e-01 | 0.951 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.725811e-01 | 0.763 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.298006e-01 | 0.887 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 1.608910e-01 | 0.793 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.969047e-01 | 0.706 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.969047e-01 | 0.706 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.336871e-01 | 0.874 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.336871e-01 | 0.874 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.951216e-01 | 0.710 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.109213e-01 | 0.955 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.940518e-01 | 0.712 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.940518e-01 | 0.712 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 1.940518e-01 | 0.712 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.562176e-01 | 0.806 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.534637e-01 | 0.814 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.486263e-01 | 0.828 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.325647e-01 | 0.878 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.227315e-01 | 0.911 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.996029e-01 | 0.700 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.121490e-01 | 0.950 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.411138e-01 | 0.850 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.422847e-01 | 0.847 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.608910e-01 | 0.793 | 1 | 1 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.608910e-01 | 0.793 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.790947e-01 | 0.747 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 1.790947e-01 | 0.747 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.969047e-01 | 0.706 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.311263e-01 | 0.882 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.030487e-01 | 0.692 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.110114e-01 | 0.676 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.616494e-01 | 0.791 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.940518e-01 | 0.712 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.722641e-01 | 0.764 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.562176e-01 | 0.806 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.504823e-01 | 0.823 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.512434e-01 | 0.820 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.882671e-01 | 0.725 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.191217e-01 | 0.924 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.716089e-01 | 0.765 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.110114e-01 | 0.676 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.311263e-01 | 0.882 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.311263e-01 | 0.882 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 1.486263e-01 | 0.828 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.969047e-01 | 0.706 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 1.872354e-01 | 0.728 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.113603e-01 | 0.953 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.230671e-01 | 0.910 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.051915e-01 | 0.688 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.084161e-01 | 0.965 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.872354e-01 | 0.728 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.664764e-01 | 0.779 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.263538e-01 | 0.898 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.940518e-01 | 0.712 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.191217e-01 | 0.924 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.191217e-01 | 0.924 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.669317e-01 | 0.777 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.716089e-01 | 0.765 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.110114e-01 | 0.676 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.461240e-01 | 0.835 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.575573e-01 | 0.803 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.829291e-01 | 0.738 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.727568e-01 | 0.763 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.140714e-01 | 0.669 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.143293e-01 | 0.669 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.143293e-01 | 0.669 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.143293e-01 | 0.669 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.143293e-01 | 0.669 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.143293e-01 | 0.669 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.143293e-01 | 0.669 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 2.143293e-01 | 0.669 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.143293e-01 | 0.669 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.164734e-01 | 0.665 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.186247e-01 | 0.660 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.186247e-01 | 0.660 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.186369e-01 | 0.660 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.190044e-01 | 0.660 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.190044e-01 | 0.660 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.190044e-01 | 0.660 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.190044e-01 | 0.660 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.190044e-01 | 0.660 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.232286e-01 | 0.651 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.232286e-01 | 0.651 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.267006e-01 | 0.645 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.270226e-01 | 0.644 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.270226e-01 | 0.644 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.270226e-01 | 0.644 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.270226e-01 | 0.644 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.270226e-01 | 0.644 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.270226e-01 | 0.644 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.270226e-01 | 0.644 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.270226e-01 | 0.644 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.278453e-01 | 0.642 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.278816e-01 | 0.642 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.278816e-01 | 0.642 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.313770e-01 | 0.636 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.313770e-01 | 0.636 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.313770e-01 | 0.636 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.313770e-01 | 0.636 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.313770e-01 | 0.636 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.313770e-01 | 0.636 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.313770e-01 | 0.636 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 2.313770e-01 | 0.636 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.313770e-01 | 0.636 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.313770e-01 | 0.636 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.336281e-01 | 0.631 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.336281e-01 | 0.631 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.350611e-01 | 0.629 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.350611e-01 | 0.629 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.350611e-01 | 0.629 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.350611e-01 | 0.629 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.431155e-01 | 0.614 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.431155e-01 | 0.614 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.431155e-01 | 0.614 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.431155e-01 | 0.614 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.431155e-01 | 0.614 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.431155e-01 | 0.614 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.439394e-01 | 0.613 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.445355e-01 | 0.612 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.480557e-01 | 0.605 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 2.480557e-01 | 0.605 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.480557e-01 | 0.605 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.480557e-01 | 0.605 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.480557e-01 | 0.605 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.480557e-01 | 0.605 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.480557e-01 | 0.605 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.488889e-01 | 0.604 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.510152e-01 | 0.600 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.510152e-01 | 0.600 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.511811e-01 | 0.600 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.511811e-01 | 0.600 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.511811e-01 | 0.600 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.511811e-01 | 0.600 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.512703e-01 | 0.600 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.568538e-01 | 0.590 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.589624e-01 | 0.587 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.592538e-01 | 0.586 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.592538e-01 | 0.586 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.627109e-01 | 0.581 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.630721e-01 | 0.580 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.630721e-01 | 0.580 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.630721e-01 | 0.580 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.643735e-01 | 0.578 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 2.643735e-01 | 0.578 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.643735e-01 | 0.578 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.643735e-01 | 0.578 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.643735e-01 | 0.578 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 2.643735e-01 | 0.578 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.673294e-01 | 0.573 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.673294e-01 | 0.573 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.673294e-01 | 0.573 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.673294e-01 | 0.573 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.673294e-01 | 0.573 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 2.673294e-01 | 0.573 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.673294e-01 | 0.573 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.673294e-01 | 0.573 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.673294e-01 | 0.573 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.685846e-01 | 0.571 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.744734e-01 | 0.561 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.751730e-01 | 0.560 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.754040e-01 | 0.560 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.754040e-01 | 0.560 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.754040e-01 | 0.560 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.754040e-01 | 0.560 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.803382e-01 | 0.552 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.803382e-01 | 0.552 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.803382e-01 | 0.552 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 2.803382e-01 | 0.552 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.803382e-01 | 0.552 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.803382e-01 | 0.552 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.803754e-01 | 0.552 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.803754e-01 | 0.552 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.834740e-01 | 0.547 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.834740e-01 | 0.547 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.834740e-01 | 0.547 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.834740e-01 | 0.547 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.915357e-01 | 0.535 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.922125e-01 | 0.534 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.959574e-01 | 0.529 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.959574e-01 | 0.529 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.959574e-01 | 0.529 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.959574e-01 | 0.529 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.959574e-01 | 0.529 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.959574e-01 | 0.529 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.959574e-01 | 0.529 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.981443e-01 | 0.526 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.995856e-01 | 0.523 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.995856e-01 | 0.523 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.995856e-01 | 0.523 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.040829e-01 | 0.517 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.076206e-01 | 0.512 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.076206e-01 | 0.512 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.091373e-01 | 0.510 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.100267e-01 | 0.509 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.112386e-01 | 0.507 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 3.112386e-01 | 0.507 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.112386e-01 | 0.507 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.112386e-01 | 0.507 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.112386e-01 | 0.507 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.112386e-01 | 0.507 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.156374e-01 | 0.501 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.156374e-01 | 0.501 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.159742e-01 | 0.500 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.171718e-01 | 0.499 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 3.176449e-01 | 0.498 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.236332e-01 | 0.490 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.236332e-01 | 0.490 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.236332e-01 | 0.490 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.236332e-01 | 0.490 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.236332e-01 | 0.490 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.236332e-01 | 0.490 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.236332e-01 | 0.490 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.236332e-01 | 0.490 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.236332e-01 | 0.490 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.236332e-01 | 0.490 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.239320e-01 | 0.490 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.261814e-01 | 0.487 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.261890e-01 | 0.487 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.261890e-01 | 0.487 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 3.261890e-01 | 0.487 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.261890e-01 | 0.487 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.261890e-01 | 0.487 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.261890e-01 | 0.487 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.278741e-01 | 0.484 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.316050e-01 | 0.479 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.316050e-01 | 0.479 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.316050e-01 | 0.479 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.316050e-01 | 0.479 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.316050e-01 | 0.479 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.316050e-01 | 0.479 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.316050e-01 | 0.479 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.338237e-01 | 0.476 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.338237e-01 | 0.476 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.395501e-01 | 0.469 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.408157e-01 | 0.467 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.408157e-01 | 0.467 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.408157e-01 | 0.467 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.408157e-01 | 0.467 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 3.408157e-01 | 0.467 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.408157e-01 | 0.467 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.408157e-01 | 0.467 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.436301e-01 | 0.464 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.457153e-01 | 0.461 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.474660e-01 | 0.459 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.488883e-01 | 0.457 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 3.551259e-01 | 0.450 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 3.551259e-01 | 0.450 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.551259e-01 | 0.450 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.551259e-01 | 0.450 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 3.551259e-01 | 0.450 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.551259e-01 | 0.450 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.551259e-01 | 0.450 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.551259e-01 | 0.450 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.551259e-01 | 0.450 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.551259e-01 | 0.450 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.551259e-01 | 0.450 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.551259e-01 | 0.450 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 3.551259e-01 | 0.450 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.632002e-01 | 0.440 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.642821e-01 | 0.439 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.682877e-01 | 0.434 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.691262e-01 | 0.433 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.691262e-01 | 0.433 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.691262e-01 | 0.433 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.691262e-01 | 0.433 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 3.691262e-01 | 0.433 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 3.691262e-01 | 0.433 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.710140e-01 | 0.431 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.710140e-01 | 0.431 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.710140e-01 | 0.431 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 3.732158e-01 | 0.428 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.787894e-01 | 0.422 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.787894e-01 | 0.422 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.787894e-01 | 0.422 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 3.828234e-01 | 0.417 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.828234e-01 | 0.417 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 3.828234e-01 | 0.417 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.828234e-01 | 0.417 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.865244e-01 | 0.413 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.865244e-01 | 0.413 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.865244e-01 | 0.413 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.865244e-01 | 0.413 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.865244e-01 | 0.413 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.871175e-01 | 0.412 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.929881e-01 | 0.406 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.942170e-01 | 0.404 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.948902e-01 | 0.404 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.962241e-01 | 0.402 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.962241e-01 | 0.402 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.962241e-01 | 0.402 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.982910e-01 | 0.400 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.018656e-01 | 0.396 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.035641e-01 | 0.394 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.046851e-01 | 0.393 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.093346e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.093346e-01 | 0.388 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.093346e-01 | 0.388 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.093346e-01 | 0.388 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.093346e-01 | 0.388 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.093346e-01 | 0.388 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.093346e-01 | 0.388 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.093346e-01 | 0.388 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.094683e-01 | 0.388 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.094683e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.094683e-01 | 0.388 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.094683e-01 | 0.388 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.121460e-01 | 0.385 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.163161e-01 | 0.381 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.221044e-01 | 0.375 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.221612e-01 | 0.375 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.221612e-01 | 0.375 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.221612e-01 | 0.375 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.221612e-01 | 0.375 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.245299e-01 | 0.372 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.319245e-01 | 0.365 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.319859e-01 | 0.365 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.319859e-01 | 0.365 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.347101e-01 | 0.362 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.347101e-01 | 0.362 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.347101e-01 | 0.362 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 4.347101e-01 | 0.362 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.347101e-01 | 0.362 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.347101e-01 | 0.362 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.393901e-01 | 0.357 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.393901e-01 | 0.357 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.393901e-01 | 0.357 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.393901e-01 | 0.357 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.393901e-01 | 0.357 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.393901e-01 | 0.357 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.393901e-01 | 0.357 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.393901e-01 | 0.357 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.393901e-01 | 0.357 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.463974e-01 | 0.350 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.469872e-01 | 0.350 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.469872e-01 | 0.350 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.469872e-01 | 0.350 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.469872e-01 | 0.350 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.469872e-01 | 0.350 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 4.469872e-01 | 0.350 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 4.469872e-01 | 0.350 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.469872e-01 | 0.350 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.507362e-01 | 0.346 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.539748e-01 | 0.343 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.540384e-01 | 0.343 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.540384e-01 | 0.343 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.540384e-01 | 0.343 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.540384e-01 | 0.343 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.589983e-01 | 0.338 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.589983e-01 | 0.338 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.589983e-01 | 0.338 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 4.612802e-01 | 0.336 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.612802e-01 | 0.336 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.620285e-01 | 0.335 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.676370e-01 | 0.330 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.676370e-01 | 0.330 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.684656e-01 | 0.329 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.707494e-01 | 0.327 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.707494e-01 | 0.327 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 4.707494e-01 | 0.327 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.707494e-01 | 0.327 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 4.707494e-01 | 0.327 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.707494e-01 | 0.327 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.732196e-01 | 0.325 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.822459e-01 | 0.317 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.822459e-01 | 0.317 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.822459e-01 | 0.317 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.822459e-01 | 0.317 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.822459e-01 | 0.317 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.822459e-01 | 0.317 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.826637e-01 | 0.316 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.834729e-01 | 0.316 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.843039e-01 | 0.315 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.843039e-01 | 0.315 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.843039e-01 | 0.315 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.934933e-01 | 0.307 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.934933e-01 | 0.307 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.934933e-01 | 0.307 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.934933e-01 | 0.307 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.934933e-01 | 0.307 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.937308e-01 | 0.307 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.966258e-01 | 0.304 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.983740e-01 | 0.302 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.044971e-01 | 0.297 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.044971e-01 | 0.297 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 5.044971e-01 | 0.297 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.067279e-01 | 0.295 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.103459e-01 | 0.292 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.103459e-01 | 0.292 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.103459e-01 | 0.292 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.103459e-01 | 0.292 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.115126e-01 | 0.291 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.115126e-01 | 0.291 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.152625e-01 | 0.288 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.152625e-01 | 0.288 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.152625e-01 | 0.288 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.152625e-01 | 0.288 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.152625e-01 | 0.288 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.152625e-01 | 0.288 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.152625e-01 | 0.288 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.152625e-01 | 0.288 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 5.152625e-01 | 0.288 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.152625e-01 | 0.288 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.152625e-01 | 0.288 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.167605e-01 | 0.287 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.167605e-01 | 0.287 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.167605e-01 | 0.287 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.171136e-01 | 0.286 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.171136e-01 | 0.286 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.221832e-01 | 0.282 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.238190e-01 | 0.281 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.257947e-01 | 0.279 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.257947e-01 | 0.279 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.257947e-01 | 0.279 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.257947e-01 | 0.279 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.257947e-01 | 0.279 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.257947e-01 | 0.279 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.257947e-01 | 0.279 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.257947e-01 | 0.279 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.360987e-01 | 0.271 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.360987e-01 | 0.271 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.360987e-01 | 0.271 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 5.360987e-01 | 0.271 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.360987e-01 | 0.271 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.360987e-01 | 0.271 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.360987e-01 | 0.271 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 5.363805e-01 | 0.271 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.368691e-01 | 0.270 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.379478e-01 | 0.269 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.388477e-01 | 0.269 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.435570e-01 | 0.265 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.435570e-01 | 0.265 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.461793e-01 | 0.263 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.461793e-01 | 0.263 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.461793e-01 | 0.263 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.461793e-01 | 0.263 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.461793e-01 | 0.263 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 5.473440e-01 | 0.262 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.481577e-01 | 0.261 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.534125e-01 | 0.257 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.560416e-01 | 0.255 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.560416e-01 | 0.255 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.563966e-01 | 0.255 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.627198e-01 | 0.250 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.656901e-01 | 0.247 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.656901e-01 | 0.247 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 5.685666e-01 | 0.245 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.689783e-01 | 0.245 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.751295e-01 | 0.240 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.751295e-01 | 0.240 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.751295e-01 | 0.240 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.751295e-01 | 0.240 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.751295e-01 | 0.240 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.813005e-01 | 0.236 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.843643e-01 | 0.233 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.931099e-01 | 0.227 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.931099e-01 | 0.227 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.931099e-01 | 0.227 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.933622e-01 | 0.227 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.933622e-01 | 0.227 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.933989e-01 | 0.227 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.933989e-01 | 0.227 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.933989e-01 | 0.227 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.933989e-01 | 0.227 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.992953e-01 | 0.222 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.022377e-01 | 0.220 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.022377e-01 | 0.220 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.075832e-01 | 0.216 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.075832e-01 | 0.216 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.108849e-01 | 0.214 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.108849e-01 | 0.214 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.108849e-01 | 0.214 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.108849e-01 | 0.214 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.108849e-01 | 0.214 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.109658e-01 | 0.214 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.109658e-01 | 0.214 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.167034e-01 | 0.210 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.167034e-01 | 0.210 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.193447e-01 | 0.208 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.193447e-01 | 0.208 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.193447e-01 | 0.208 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.193447e-01 | 0.208 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.193447e-01 | 0.208 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.213461e-01 | 0.207 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.259206e-01 | 0.203 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.276210e-01 | 0.202 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.276210e-01 | 0.202 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.279835e-01 | 0.202 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.335263e-01 | 0.198 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.357178e-01 | 0.197 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.357178e-01 | 0.197 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.357178e-01 | 0.197 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.357178e-01 | 0.197 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.357178e-01 | 0.197 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.390045e-01 | 0.194 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.390045e-01 | 0.194 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.436391e-01 | 0.191 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.436391e-01 | 0.191 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.436391e-01 | 0.191 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.436391e-01 | 0.191 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.436391e-01 | 0.191 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.436391e-01 | 0.191 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 6.436391e-01 | 0.191 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.444182e-01 | 0.191 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.513887e-01 | 0.186 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.513887e-01 | 0.186 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.513887e-01 | 0.186 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.513887e-01 | 0.186 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.550533e-01 | 0.184 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.589701e-01 | 0.181 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.589701e-01 | 0.181 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.589701e-01 | 0.181 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.602751e-01 | 0.180 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.654335e-01 | 0.177 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.654335e-01 | 0.177 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.663872e-01 | 0.176 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 6.663872e-01 | 0.176 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.736434e-01 | 0.172 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.736434e-01 | 0.172 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.805307e-01 | 0.167 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.807422e-01 | 0.167 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.876870e-01 | 0.163 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.944812e-01 | 0.158 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.944812e-01 | 0.158 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.969621e-01 | 0.157 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.997912e-01 | 0.155 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.044536e-01 | 0.152 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.055669e-01 | 0.151 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 7.076305e-01 | 0.150 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.090556e-01 | 0.149 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.139920e-01 | 0.146 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.139920e-01 | 0.146 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.139920e-01 | 0.146 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.202154e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.202154e-01 | 0.143 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 7.263038e-01 | 0.139 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 7.263038e-01 | 0.139 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.268691e-01 | 0.139 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.278577e-01 | 0.138 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.322601e-01 | 0.135 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.322601e-01 | 0.135 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.322601e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.322601e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.380871e-01 | 0.132 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.380871e-01 | 0.132 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.396172e-01 | 0.131 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.419716e-01 | 0.130 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.478315e-01 | 0.126 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.478315e-01 | 0.126 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.488080e-01 | 0.126 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.493645e-01 | 0.125 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.548203e-01 | 0.122 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 7.548203e-01 | 0.122 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.548203e-01 | 0.122 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.548203e-01 | 0.122 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.597359e-01 | 0.119 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.601576e-01 | 0.119 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.653791e-01 | 0.116 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.653791e-01 | 0.116 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.704872e-01 | 0.113 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.704872e-01 | 0.113 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.746290e-01 | 0.111 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.754844e-01 | 0.110 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.820929e-01 | 0.107 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.851557e-01 | 0.105 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.944115e-01 | 0.100 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.058550e-01 | 0.094 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 8.117471e-01 | 0.091 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.117471e-01 | 0.091 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.117471e-01 | 0.091 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.198602e-01 | 0.086 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.198602e-01 | 0.086 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.213918e-01 | 0.085 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.225087e-01 | 0.085 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.237851e-01 | 0.084 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 8.237851e-01 | 0.084 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.301787e-01 | 0.081 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.313809e-01 | 0.080 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.324913e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.350554e-01 | 0.078 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.421666e-01 | 0.075 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.489721e-01 | 0.071 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.489721e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.489721e-01 | 0.071 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.522643e-01 | 0.069 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.554850e-01 | 0.068 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.586356e-01 | 0.066 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.700999e-01 | 0.060 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.707420e-01 | 0.060 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.793921e-01 | 0.056 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.835142e-01 | 0.054 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.866092e-01 | 0.052 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.866092e-01 | 0.052 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.932568e-01 | 0.049 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.938702e-01 | 0.049 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.961860e-01 | 0.048 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.969379e-01 | 0.047 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.969379e-01 | 0.047 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.006675e-01 | 0.045 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.049560e-01 | 0.043 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.070305e-01 | 0.042 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.090599e-01 | 0.041 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.136359e-01 | 0.039 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.166051e-01 | 0.038 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.185630e-01 | 0.037 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.195775e-01 | 0.036 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.199520e-01 | 0.036 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.211975e-01 | 0.036 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.220808e-01 | 0.035 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.286684e-01 | 0.032 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.303272e-01 | 0.031 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.388883e-01 | 0.027 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.397110e-01 | 0.027 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.415303e-01 | 0.026 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.434410e-01 | 0.025 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.449539e-01 | 0.025 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.589699e-01 | 0.018 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.607279e-01 | 0.017 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.615872e-01 | 0.017 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.663633e-01 | 0.015 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.670997e-01 | 0.015 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.848025e-01 | 0.007 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.886476e-01 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.898406e-01 | 0.004 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.903021e-01 | 0.004 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.906843e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.947851e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.957409e-01 | 0.002 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.960075e-01 | 0.002 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.967327e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.986311e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.987166e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.988159e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.989727e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.994754e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.998664e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999258e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999281e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |